Media Release Osteoporosis Canada and the International Osteoporosis Foundation underline their shared goal of improving clinical outcomes and preventing recurrent fractures in patients who have sustained fractures due to osteoporosis. […]

A recent study, Annual High-Dose Oral Vitamin D and Falls and Fractures in Older Women, published in the Journal of the American Medical Association (JAMA), showed that a single large […]

Denosumab A human monoclonal antibody that prevents RANKL-RANK interaction Denosumab (Bone Metabolism Regulator) Denosumab is a new class of osteoporosis treatment called a human monoclonal antibody that prevents RANKL-RANK interaction […]

A recently released Canadian research study confirms what has been shown in past preliminary studies; – inflammation of the eye as a possible side effect of bisphosphonate therapy is very […]

ONTARIO OSTEOPOROSIS STRATEGY Ontario Osteoporosis Strategy The Ontario Osteoporosis Strategy represents the vision and coordinated efforts of many groups, including the Ministry of Health and Long-Term Care (MOHLTC), Ontario Women’s […]